I suppose I'm fence sitting because Reddys have only half the motivation to push Fonda right now than they will after the sale if it goes through. I agree, Fonda forward earnings should easily eclipse $AU24m. "Should" is the word I struggle with, because a lot of things should have happened at Alchemia over the 7 years I've held, and other than Fonda getting FDA approval, I'm struggling to think of any that have.
Risk averse is what my ACL shares have become, very very risk averse.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable